Frontiers in Immunology (Sep 2024)
Varicella-zoster virus recapitulates its immune evasive behaviour in matured hiPSC-derived neurospheroids
- Jonas Govaerts,
- Jonas Govaerts,
- Jonas Govaerts,
- Elise Van Breedam,
- Sarah De Beuckeleer,
- Sarah De Beuckeleer,
- Sarah De Beuckeleer,
- Charlotte Goethals,
- Claudio Peter D’Incal,
- Julia Di Stefano,
- Siebe Van Calster,
- Tamariche Buyle-Huybrecht,
- Tamariche Buyle-Huybrecht,
- Tamariche Buyle-Huybrecht,
- Marlies Boeren,
- Marlies Boeren,
- Marlies Boeren,
- Hans De Reu,
- Hans De Reu,
- Søren R. Paludan,
- Marc Thiry,
- Marielle Lebrun,
- Catherine Sadzot-Delvaux,
- Helena Motaln,
- Boris Rogelj,
- Boris Rogelj,
- Johan Van Weyenbergh,
- Winnok H. De Vos,
- Winnok H. De Vos,
- Wim Vanden Berghe,
- Benson Ogunjimi,
- Benson Ogunjimi,
- Benson Ogunjimi,
- Benson Ogunjimi,
- Peter Delputte,
- Peter Delputte,
- Peter Ponsaerts,
- Peter Ponsaerts
Affiliations
- Jonas Govaerts
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Jonas Govaerts
- Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium
- Jonas Govaerts
- Antwerp Center for Translational Immunology and Virology (ACTIV), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Elise Van Breedam
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Sarah De Beuckeleer
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Sarah De Beuckeleer
- Laboratory of Cell Biology and Histology, Antwerp Center for Advanced Microscopy, Department of Veterinary Sciences, University of Antwerp, Wilrijk, Belgium
- Sarah De Beuckeleer
- µNEURO Research Centre of Excellence, University of Antwerp, Wilrijk, Belgium
- Charlotte Goethals
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Claudio Peter D’Incal
- Cell Death Signaling – Epigenetics Lab, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
- Julia Di Stefano
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Siebe Van Calster
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Tamariche Buyle-Huybrecht
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Tamariche Buyle-Huybrecht
- Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium
- Tamariche Buyle-Huybrecht
- Antwerp Center for Translational Immunology and Virology (ACTIV), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Marlies Boeren
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Marlies Boeren
- Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium
- Marlies Boeren
- Antwerp Center for Translational Immunology and Virology (ACTIV), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Hans De Reu
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Hans De Reu
- Flow Cytometry and Cell Sorting Core Facility (FACSUA), University of Antwerp, Antwerp, Belgium
- Søren R. Paludan
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- Marc Thiry
- Laboratory of Cell and Tissue Biology, GIGA-Neurosciences, Cell Biology L3, University of Liège, Liege, Belgium
- Marielle Lebrun
- 0Laboratory of Virology and Immunology, GIGA-Infection, Inflammation and Immunity, University of Liège, Liège, Belgium
- Catherine Sadzot-Delvaux
- 0Laboratory of Virology and Immunology, GIGA-Infection, Inflammation and Immunity, University of Liège, Liège, Belgium
- Helena Motaln
- 1Department of Biotechnology, Jozef Stefan Institute, Ljubljana, Slovenia
- Boris Rogelj
- 1Department of Biotechnology, Jozef Stefan Institute, Ljubljana, Slovenia
- Boris Rogelj
- 2Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia
- Johan Van Weyenbergh
- 3Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, Leuven, Belgium
- Winnok H. De Vos
- Laboratory of Cell Biology and Histology, Antwerp Center for Advanced Microscopy, Department of Veterinary Sciences, University of Antwerp, Wilrijk, Belgium
- Winnok H. De Vos
- µNEURO Research Centre of Excellence, University of Antwerp, Wilrijk, Belgium
- Wim Vanden Berghe
- Cell Death Signaling – Epigenetics Lab, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
- Benson Ogunjimi
- Antwerp Center for Translational Immunology and Virology (ACTIV), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Benson Ogunjimi
- 4Antwerp Unit for Data Analysis and Computation in Immunology and Sequencing (AUDACIS), Antwerp, Belgium
- Benson Ogunjimi
- 5Centre for Health Economics Research and Modelling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Benson Ogunjimi
- 6Department of Paediatrics, Antwerp University Hospital, Antwerp, Belgium
- Peter Delputte
- Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium
- Peter Delputte
- 7Infla-Med, University of Antwerp, Antwerp, Belgium
- Peter Ponsaerts
- Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium
- Peter Ponsaerts
- Flow Cytometry and Cell Sorting Core Facility (FACSUA), University of Antwerp, Antwerp, Belgium
- DOI
- https://doi.org/10.3389/fimmu.2024.1458967
- Journal volume & issue
-
Vol. 15
Abstract
Varicella-zoster virus (VZV) encephalitis and meningitis are potential central nervous system (CNS) complications following primary VZV infection or reactivation. With Type-I interferon (IFN) signalling being an important first line cellular defence mechanism against VZV infection by the peripheral tissues, we here investigated the triggering of innate immune responses in a human neural-like environment. For this, we established and characterised 5-month matured hiPSC-derived neurospheroids (NSPHs) containing neurons and astrocytes. Subsequently, NSPHs were infected with reporter strains of VZV (VZVeGFP-ORF23) or Sendai virus (SeVeGFP), with the latter serving as an immune-activating positive control. Live cell and immunocytochemical analyses demonstrated VZVeGFP-ORF23 infection throughout the NSPHs, while SeVeGFP infection was limited to the outer NSPH border. Next, NanoString digital transcriptomics revealed that SeVeGFP-infected NSPHs activated a clear Type-I IFN response, while this was not the case in VZVeGFP-ORF23-infected NSPHs. Moreover, the latter displayed a strong suppression of genes related to IFN signalling and antigen presentation, as further demonstrated by suppression of IL-6 and CXCL10 production, failure to upregulate Type-I IFN activated anti-viral proteins (Mx1, IFIT2 and ISG15), as well as reduced expression of CD74, a key-protein in the MHC class II antigen presentation pathway. Finally, even though VZVeGFP-ORF23-infection seems to be immunologically ignored in NSPHs, its presence does result in the formation of stress granules upon long-term infection, as well as disruption of cellular integrity within the infected NSPHs. Concluding, in this study we demonstrate that 5-month matured hiPSC-derived NSPHs display functional innate immune reactivity towards SeV infection, and have the capacity to recapitulate the strong immune evasive behaviour towards VZV.
Keywords
- human iPSc
- neurospheroids
- varicella-zoster virus
- type-I interferon signalling
- antigen presentation
- stress granules